we are a clinical-stage biotechnology company focused on developing and commercializing novel cancer therapies that target the tumor microenvironment.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

CEO

Helen Torley

halozyme.com/ →

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance